cardiovascular disorders
Drugs for Heart Failure
Drug selection references
1.Packer M, Anker SD, Butler J, et al: Cardiovascular and renal outcomes withempagliflozinin heart failure.N Engl J Med383(15):1413-1424, 2020. doi: 10.1056/NEJMoa2022190. Epub 2020 Aug 28. PMID: 32865377. 2.Anker SD, Butler J, Filippatos G, et al:Empagliflozinin heart failure with a preserved ejection fraction.N Engl J Med385(16):1451-1461, 2021. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27. PMID: 34449189. 